Page 65 - IMO-1-1

Innovative Medicines & Omics Antioxidant nanomedicines for therapies

270. Chen Z, Qi F, Qiu W, et al. Hydrogenated germanene ferroptosis‐targeting and reactive oxygen/nitrogen
nanosheets as an antioxidative defense agent for species‐scavenging nanozyme for alleviating acute kidney
acute kidney injury treatment. Adv Sci (Weinh). injury. Adv Funct Mater. 2021;32(10):2109221.
2022;9(33):e2202933.
doi: 10.1002/adfm.202109221
doi: 10.1002/advs.202202933
282. Eckardt KU, Coresh J, Devuyst O, et al. Evolving
271. Weng Q, Sun H, Fang C, et al. Catalytic activity tunable ceria importance of kidney disease: from subspecialty to global
nanoparticles prevent chemotherapy-induced acute kidney health burden. Lancet. 2013;382(9887):158-169.
injury without interference with chemotherapeutics. Nat doi: 10.1016/S0140-6736(13)60439-0
Commun. 2021;12(1):1436.
283. Kovesdy CP. Epidemiology of chronic kidney disease: An
doi: 10.1038/s41467-021-21714-2
update 2022. Kidney Int Suppl (2011). 2022;12(1):7-11.
272. Meng L, Feng J, Gao J, et al. Reactive oxygen species- and doi: 10.1016/j.kisu.2021.11.003
cell-free DNA-scavenging Mn(3)O(4) nanozymes for
acute kidney injury therapy. ACS Appl Mater Interfaces. 284. Galvan DL, Green NH, Danesh FR. The hallmarks of
2022;14(45):50649-50663. mitochondrial dysfunction in chronic kidney disease.
Kidney Int. 2017;92(5):1051-1057.
doi: 10.1021/acsami.2c16305
doi: 10.1016/j.kint.2017.05.034
273. Ni D, Jiang D, Kutyreff CJ, et al. Molybdenum-based
nanoclusters act as antioxidants and ameliorate acute 285. Ho HJ, Shirakawa H. Oxidative stress and mitochondrial
kidney injury in mice. Nat Commun. 2018;9(1):5421. dysfunction in chronic kidney disease. Cells. 2023;12(1):88.
doi: 10.1038/s41467-018-07890-8 doi: 10.3390/cells12010088
274. Choi HS, Mathew AP, Uthaman S, et al. Inflammation- 286. Daenen K, Andries A, Mekahli D, Van Schepdael A,
sensing catalase-mimicking nanozymes alleviate acute Jouret F, Bammens B. Oxidative stress in chronic kidney
kidney injury via reversing local oxidative stress. disease. Pediatr Nephrol. 2019;34(6):975-991.
J Nanobiotechnol. 2022;20(1):205. doi: 10.1007/s00467-018-4005-4
doi: 10.1186/s12951-022-01410-z 287. Small DM, Coombes JS, Bennett N, Johnson DW, Gobe
275. Yang WS, Stockwell BR. Ferroptosis: Death by lipid GC. Oxidative stress, anti-oxidant therapies and chronic
peroxidation. Trends Cell Biol. 2016;26(3):165-176. kidney disease. Nephrology (Carlton). 2012;17(4):311-321.
doi: 10.1016/j.tcb.2015.10.014 doi: 10.1111/j.1440-1797.2012.01572.x
276. Stockwell BR, Friedmann Angeli JP, Bayir H, et al. 288. Adhikari A, Mondal S, Chatterjee T, et al. Redox
Ferroptosis: A regulated cell death nexus linking nanomedicine ameliorates chronic kidney disease (CKD)
metabolism, redox biology, and disease. Cell. by mitochondrial reconditioning in mice. Commun Biol.
2017;171(2):273-285. 2021;4(1):1013.
doi: 10.1016/j.cell.2017.09.021 doi: 10.1038/s42003-021-02546-8
277. Jiang X, Stockwell BR, Conrad M. Ferroptosis: 289. Kolff WJ. Hemodialysis in the management of renal
Mechanisms, biology and role in disease. Nat Rev Mol Cell disease. Annu Rev Med. 1972;23(1):321-332.
Biol. 2021;22(4):266-282. doi: 10.1146/annurev.me.23.020172.001541
doi: 10.1038/s41580-020-00324-8 290. Liakopoulos V, Roumeliotis S, Zarogiannis S,
278. Dixon SJ, Stockwell BR. The role of iron and reactive oxygen Eleftheriadis T, Mertens PR. Oxidative stress in
species in cell death. Nat Chem Biol. 2014;10(1):9-17. hemodialysis: Causative mechanisms, clinical implications,
and possible therapeutic interventions. Semin Dial.
doi: 10.1038/nchembio.1416
2019;32(1):58-71.
279. Ni L, Yuan C, Wu X. Targeting ferroptosis in acute kidney doi: 10.1111/sdi.12745
injury. Cell Death Dis. 2022;13(2):182.
291. Wei Z, Peng G, Zhao Y, et al. Engineering antioxidative
doi: 10.1038/s41419-022-04628-9
cascade metal-phenolic nanozymes for alleviating
280. Hosohata K, Harnsirikarn T, Chokesuwattanaskul S. oxidative stress during extracorporeal blood purification.
Ferroptosis: A potential therapeutic target in acute kidney ACS Nano. 2022;16(11):18329-18343.
injury. Int J Mol Sci. 2022;23(12):6583.
doi: 10.1021/acsnano.2c06186
doi: 10.3390/ijms23126583
292. Park HS, Kim SR, Lee YC. Impact of oxidative stress on
281. Wang K, Zhang Y, Mao W, et al. Engineering ultrasmall lung diseases. Respirology. 2009;14(1):27-38.

Volume 1 Issue 1 (2024) 59 doi: 10.36922/imo.2527